To test this, we treated BC cells with actinomycin-D (inhibitor of RNA synthesis) and indeed the LBD portion of ESR1 transcript was significantly more stable than the FL-specific in MCF-7 FulvRes and TNBC cells (Supplementary Fig. 2g). This evidence concerns the gene ESR1 and breast cancer.